A Multicenter Observational Study to Understand the Clinical Characteristics, Treatment Patterns and Access to Novel Therapies of Patients With Diffuse Large B-Cell Lymphoma in the MEA Region
Clinical trial NCT07065344 · RECRUITING
Trial details
- NCT number
- NCT07065344
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-23
- Primary completion
- 2027-01-31
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.